BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24552158)

  • 1. Molecular determinants of context-dependent progesterone receptor action in breast cancer.
    Hagan CR; Lange CA
    BMC Med; 2014 Feb; 12():32. PubMed ID: 24552158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of progesterone antagonists.
    Leonhardt SA; Edwards DP
    Exp Biol Med (Maywood); 2002 Dec; 227(11):969-80. PubMed ID: 12486206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormones, steroid receptors, and breast cancer stem cells.
    Finlay-Schultz J; Sartorius CA
    J Mammary Gland Biol Neoplasia; 2015 Jun; 20(1-2):39-50. PubMed ID: 26265122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer.
    Klijn JG; Setyono-Han B; Foekens JA
    Steroids; 2000; 65(10-11):825-30. PubMed ID: 11108894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.
    Richer JK; Jacobsen BM; Manning NG; Abel MG; Wolf DM; Horwitz KB
    J Biol Chem; 2002 Feb; 277(7):5209-18. PubMed ID: 11717311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and breast cancer.
    Lange CA; Yee D
    Womens Health (Lond); 2008 Mar; 4(2):151-62. PubMed ID: 19072517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
    Purmonen S; Manninen T; Pennanen P; Ylikomi T
    Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to defining a role for progesterone in breast cancer.
    Lange CA
    Steroids; 2008 Oct; 73(9-10):914-21. PubMed ID: 18243264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational developments for the treatment of progesterone-dependent diseases.
    Möller C; Hoffmann J; Kirkland TA; Schwede W
    Expert Opin Investig Drugs; 2008 Apr; 17(4):469-79. PubMed ID: 18363513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
    Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
    J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation.
    Cenciarini ME; Proietti CJ
    Steroids; 2019 Dec; 152():108503. PubMed ID: 31562879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.
    Proietti CJ; Cenciarini ME; Elizalde PV
    Steroids; 2018 May; 133():75-81. PubMed ID: 29317254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
    Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
    Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
    Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progesterone receptor structure and action in breast cancer cells.
    Bettuzzi S; Robinson A; Fuchs-Young R; Greene GL
    Cancer Treat Res; 1992; 61():301-15. PubMed ID: 1360239
    [No Abstract]   [Full Text] [Related]  

  • 17. The structure and function of progesterone receptors in breast cancer.
    Horwitz KB
    J Steroid Biochem; 1987; 27(1-3):447-57. PubMed ID: 3320537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
    Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
    Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
    Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
    PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and regulation of estrogen and progesterone receptors in breast cancer.
    Read LD; Katzenellenbogen BS
    Cancer Treat Res; 1992; 61():277-99. PubMed ID: 1360237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.